A detailed history of Fragasso Group Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 8,979 shares of TMO stock, worth $4.99 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
8,979
Previous 9,125 1.6%
Holding current value
$4.99 Million
Previous $5.05 Million 10.05%
% of portfolio
0.45%
Previous 0.43%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$531.86 - $624.21 $77,651 - $91,134
-146 Reduced 1.6%
8,979 $5.55 Million
Q2 2024

Jul 08, 2024

SELL
$541.52 - $599.02 $1.32 Million - $1.46 Million
-2,438 Reduced 21.08%
9,125 $5.05 Million
Q1 2024

Apr 10, 2024

SELL
$528.82 - $599.43 $92,543 - $104,900
-175 Reduced 1.49%
11,563 $6.72 Million
Q4 2023

Jan 08, 2024

BUY
$431.41 - $532.94 $225,196 - $278,194
522 Added 4.65%
11,738 $6.23 Million
Q3 2023

Dec 06, 2023

SELL
$498.29 - $574.41 $289,008 - $333,157
-580 Reduced 4.92%
11,216 $5.68 Million
Q2 2023

Jul 10, 2023

SELL
$508.46 - $591.13 $1.45 Million - $1.68 Million
-2,848 Reduced 19.45%
11,796 $6.15 Million
Q1 2023

Apr 13, 2023

BUY
$535.0 - $604.82 $500,225 - $565,506
935 Added 6.82%
14,644 $8.44 Million
Q4 2022

Jan 24, 2023

SELL
$484.71 - $571.37 $6.64 Million - $7.83 Million
-13,709 Closed
0 $0
Q4 2022

Jan 24, 2023

BUY
$484.71 - $571.37 $375,650 - $442,811
775 Added 5.99%
13,709 $0
Q3 2022

Oct 13, 2022

BUY
$507.19 - $604.49 $1.14 Million - $1.36 Million
2,249 Added 21.05%
12,934 $6.56 Million
Q2 2022

Aug 30, 2022

BUY
$500.9 - $612.21 $5.35 Million - $6.54 Million
10,685 New
10,685 $5.81 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $218B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Fragasso Group Inc. Portfolio

Follow Fragasso Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.